A perspective on HIV/AIDS: What could the future hold?

REFERENCES

• Auver , T. B. , Males , S. , Puren , A. , Taljaard , D. , CaraëL , M. and Williams , B. 2004 . Can highly active antiretroviral therapy reduce the spread of HIV? . Journal of Acquired Immune Deficiency Syndromes , 36 : 613 – 621 .
   Google Scholar
• Barre-Sinoussi , F. , Chermann , J. C. , Rey , F. , Nugeyre , M. T. , Chamaret , S. , Gruest , J. , Dauguet , C. , Axler-Blin , C. , Vézinet-Brun , F. , Rouzioux , C. , Rozenbaum , W. and Montagnier , L. 1983 . Isolation of a T-lymphotropic retrovirus from a patient at risk for acquiring immune deficiency syndrome (AIDS) . Science , 220 : 868 – 871 .
   PubMed Web of Science ®Google Scholar
• Berkley , S. F. and Koff , W. C. 2007 . Scientific and policy challenges to development of an AIDS vaccine . The Lancet , 370 : 94 – 101 .
   PubMed Web of Science ®Google Scholar
• Betts , M. R. , Nason , M. C. , West , S. M. , De Rosa , S. C. , Migueles , S. A. , Abraham , J. , Lederman , M. M. , Benito , J. M. , Goepfert , P. A. , Connors , M. , Roederer , M. and Koup , R. A. 2006 . HIV nonprogressors preferentially maintain highly functional HIV-specific CD8 + T cells . Blood , 107 : 4781 – 4789 .
   PubMed Web of Science ®Google Scholar
• Chantry , D. 2004 . Hiv entry and fusion inhibitors . Expert Opinion on Emerging Drugs , 9 ( 1 ) : 1 – 7 .
   PubMedGoogle Scholar
• Cohen , M. L. 2000 . Changing patterns of infectious disease . Nature , 406 : 762 – 767 .
   PubMed Web of Science ®Google Scholar
• Cohen , M. S. , Gay , C. , Kashuba , A. D. , Blower , S. and Paxton , L. 2007 . Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1 . Annals of Internal Medicine , 146 ( 8 ) : 591 – 601 .
   PubMed Web of Science ®Google Scholar
• Department of Health . 2007 . National HIV and syphilis antenatal seroprevalence survey in South Africa , Online: http://www.doh.gov/docs/reports-f.html (accessed 12 December 2007)
   Google Scholar
• Esté , J. A. and Telenti , A. 2007 . HIV entry inhibitors . The Lancet , 370 ( 9581 ) : 81 – 88 .
   PubMed Web of Science ®Google Scholar
• Fischl , M. A. , Richman , D. D. Grieco , M. H. 1987 . The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial . New England Journal of Medicine , 317 : 185 – 191 .
   PubMed Web of Science ®Google Scholar
• Gallo , R. C. , Sarin , P. S. , Gelmann , E. P. , Robert-Guroff , M. , Richardson , E. , Kalyanaraman , V. S. , Mann , D. , Sidhu , G. D. , Stahl , R. E. , Zolla-Pazner , S. , Leibowitch , J. and Popovic , M. 1983 . Isolation of human T-cell leukaemia virus in acquired immune deficiency syndrome (AIDS) . Science , 220 : 865 – 867 .
   PubMed Web of Science ®Google Scholar
• Gallo , R. C. 2005 . The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years . The Lancet , 366 : 1894 – 1898 .
   Google Scholar
• Hammer , S. M. , Saag , M. S. , Schechter , M. , Montaner , J. S.G. , Schooley , R. T. , Jacobsen , D. M. , Thompson , M. A. , Carpenter , C. C.J. , Fischl , M. A. , Gazzard , B. G. , Gatell , J. M. , Hirsch , M. S. , Katzenstein , D. A. , Richman , D. D. , Vella , S. , Yeni , P. G. and Volberding , P. A. 2006 . Treatment of adult HIV infection. 2006 recommendations of the International AIDS Society USA Panel . Journal of the American Medical Association , 296 ( 7 ) : 827 – 843 .
   PubMed Web of Science ®Google Scholar
• Heeney , J. L. , Dalgleish , A. G. and Weiss , R. A. 2006 . Origins of HIV and the evolution of resistance to AIDS . Science , 131 : 462 – 466 .
   Google Scholar
• Hirsch , M. S. and D'Aquila , R. T. 1993 . Therapy for human immunodeficiency virus infection . New England Journal of Medicine , 328 : 1686 – 1695 .
   PubMed Web of Science ®Google Scholar
• Horton , R. 2004 . AIDS: the elusive vaccine . New York Review of Books , 51 : 14 Online: http://www.nybooks.com/article/17400 (accessed 26 September 2007)
   Google Scholar
• Johnston , M. I. and Fauci , A. S. 2007 . An HIV vaccine evolving concepts . New England Journal of Medicine , 356 ( 20 ) : 2073 – 2081 .
   PubMed Web of Science ®Google Scholar
• Kahn , J. G. , Marseille , E. and Auvert , B. 2006 . Cost-effectiveness of male circumcision for HIV prevention in a South African setting . PLoS Medicine , 3 ( 12 ) : 2349 – 2358 .
   Web of Science ®Google Scholar
• Korber , B. , Gaschen , B. , Yusim , K. , Thakallapally , R. , Kesmir , C. and Detours , V. 2001 . Evolutionary and immunological implications of contemporary HIV-1 variation . British Medical Bulletin , 58 : 19 – 42 .
   PubMed Web of Science ®Google Scholar
• Levin , B. R. , Bull , J. J. and Stewart , F. M. 2001 . Epidemiology, evolution and future of the HIV/AIDS pandemic . Emerging Infectious Diseases , 7 ( 3 ) : 505 – 511 .
   Google Scholar
• Markel , H. 2005 . The search for effective HIV vaccines . New England Journal of Medicine , 353 ( 8 ) : 753 – 757 .
   Google Scholar
• Morbidity and Mortality Weekly Report . 1981 . Pneumocystispneumonia in Los Angeles . Centers for Disease Control and Prevention , 30 ( 21 ) : 3
   Google Scholar
• Morbidity and Mortality Weekly Report . 2005 . Updated US Public Health Service Guidelines for the management of Occupational Exposures to HIV and recommendations for postexposure prophylaxis , 54 ( RR-9 ) : 1 – 17 .
   Google Scholar
• Nair , V. and Chi , G. 2007 . Hiv integrase inhibitors as therapeutic agents in AIDS . Reviews in Medical Virology , 17 ( 4 ) : 277 – 295 .
   Google Scholar
• National Institute of Allergy and Infectious Diseases (Niaid) . 2007 . Statement: Immunizations are discontinued in two HIV vaccine trials , Online: http://www3.niaid.nih.gov/news/newsreleases/2007/step_statement.htm (accessed 1 October 2007)
   Google Scholar
• Perelson , A. S. , Neumann , A. U. , Markowitz , M. , Leonard , J. M. and Ho , D. D. 1996 . HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time . Science , 271 ( 5255 ) : 1582 – 1586 .
   PubMed Web of Science ®Google Scholar
• Pitisuttithum , P. , Gilbert , P. , Gurwith , M. , Heyward , W. , Martin , M. Van Griensven , F. 2006 . Randomized, double-blind placebo controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand . Journal of Infectious Diseases , 194 : 1661 – 1671 .
   PubMed Web of Science ®Google Scholar
• Pomerantz , R. J. and Horn , D. L. 2003 . Twenty years of therapy for HIV-1 infection . Nature Medicine , 9 ( 7 ) : 867 – 873 .
   Google Scholar
• Ramjee , G. , Govinden , R. , Morar , N. S. and Mbewu , A. 2007 . South Africa's experience of the closure of the cellulose sulphate microbicide trial . PLoS Medicine , 4 ( 7 ) : 1167 – 1173 .
   Web of Science ®Google Scholar
• Reeves , J. D. and Piefer , A. J. 2005 . Emerging drug targets for antiretroviral therapy . Drugs , 65 ( 13 ) : 1747 – 1766 .
   PubMed Web of Science ®Google Scholar
• rgp 120 Hiv Vaccine Study Group . 2005 . Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection . The Journal of Infectious Diseases , 191 : 654 – 665 .
   Google Scholar
• Sigerist , H. E. 1971 . The Great Doctors 436 New York : Dover Publications .
   Google Scholar
• The Petra Study Team . 2002 . Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial . The Lancet , 359 : 1178 – 1186 .
   PubMed Web of Science ®Google Scholar
• Veazey , R. and Lackner , A. A. 2005 . HIV swiftly guts the immune system . Nature Medicine , 5 : 469 – 470 .
   Google Scholar
• Van der Kuyl , A. C. and Cornelissen , M. 2007 . Identifying HIV-1 dual infections . Retrovirology , 4 ( 1 ) : 67
   Google Scholar
• Vermund , S. H. 2006 . Millions of life-years saved with potent anti-retroviral drugs in the United States: a celebration, with challenges . The Journal of Infectious Diseases , 194 : 1 – 5 .
   PubMed Web of Science ®Google Scholar
• Walensky , R. P. , Paltiel , A. D. , Losina , E. , Mercincavage , L. M. , Schackman , B. R. , Sax , P. E. , Weinstein , M. C. and Freedberg , K. A. 2006 . The survival benefits of AIDs treatment in the United States . The Journal of Infectious Diseases , 194 : 11 – 18 .
   PubMed Web of Science ®Google Scholar
• Wei , X. , Ghosh , S. K. , Taylor , M. E. , Johnson , V. A. , Emini , E. A. , Deutsch , P. , Lifson , J. D. , Bonhoeffer , S. , Nowak , M. A. and Hahn , B. H. 1995 . Viral dynamics in human immunodeficiency virus type 1 infection . Nature , 373 ( 6510 ) : 117 – 122 .
   PubMed Web of Science ®Google Scholar
• Williams , B. G. , Lloyd-Smith , J. O. , Gouws , E. , Hankins , C. , Getz , W. M. , Hargrove , J. , De Zoysa , I. , Dye , C. and Auvert , B. 2006 . The potential impact of male circumcision on HIV in sub-Saharan Africa . PLoS Medicine , 3 ( 7 ) : 1 – 9 .
   Google Scholar
• World Health Organization, Weekly Epidemiology Record . 1998 . Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV , 73 : 313 – 320 .
   Google Scholar
• Yusim , K. , Peeters , M. , Pybus , O. G. , Bhattacharya , T. , Delaporte , E. , Mulanga , C. , Muldoon , M. , Theiler , J. and Korber , B. 2001 . Using human immunodeficiency virus type 1 sequences to infer historical features of the acquiring immune deficiency syndrome epidemic and human immunodeficiency virus evolution . Philosophical Transactions of the Royal Society of London. Series B, Biological , 356 : 855 – 866 .
   Google Scholar
• Zhu , T. , Korber , B. T. , Nahmias , A. J. , Hooper , E. , Sharp , P. M. and Ho , D. D. 1998 . An African HIV-1 sequence from 1959 and implications for the origin of the epidemic . Nature , 391 : 594 – 596 .
   PubMed Web of Science ®Google Scholar